The American Society for Gastrointestinal Endoscopy recently released new clinical guidance on the screening for pancreatic cancer in people with genetic susceptibility (Gastrointest Endosc 2022 Feb 16. doi:10.1016/j.gie.2021.12.001). GEN’s Sarah Tilyou spoke with lead author Mandeep S. Sawhney, MD, MS, FASGE, a gastroenterologist at Beth Israel Deaconess Medical Center and an associate professor of medicine at Harvard Medical School, in Boston, about the impetus for the guidelines and what they mean to GI practice.
Trending
- FDA clears next-gen Medtronic PillCam solution suite (Mass Device)
- Oshi Health: Hybrid GI care is here to stay
- Does Your GI Practice Have a Clinical Research Program? (it could benefit your patients and practice) (Gastro Brodcast)
- Lawmakers Weigh Lifting National Restrictions on Physician-Owned Hospitals (Medscape)
- Gut Instincts: Bridging Psychology and Gastroenterology (European Medical Journal)
- New treatment strategy for MASLD (MDLinx)
- The best gastroenterology ASCs: US News (Becker’s GI & Endoscopy)
- Loren Laine, MD, on DDW Sessions You Can’t Miss (Gastroenterology & Endoscopy News)